Semi-Annual Statement Of Income

Mochida Pharmaceutical Co.,Ltd. - Filing #7300559

Concept 2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
Semi-annual statement of income
Statement of income
Net sales
51,096,000,000 JPY
49,476,000,000 JPY
Cost of sales
25,811,000,000 JPY
23,961,000,000 JPY
Ordinary profit (loss)
4,079,000,000 JPY
4,053,000,000 JPY
Gross profit (loss)
25,285,000,000 JPY
25,515,000,000 JPY
Selling, general and administrative expenses
21,492,000,000 JPY
21,563,000,000 JPY
Extraordinary income
2,000,000 JPY
27,000,000 JPY
Selling, general and administrative expenses
Advertising expenses
2,233,000,000 JPY
2,288,000,000 JPY
Bonuses
1,415,000,000 JPY
1,386,000,000 JPY
Extraordinary losses
13,000,000 JPY
31,000,000 JPY
Profit (loss) before income taxes
4,068,000,000 JPY
4,049,000,000 JPY
Operating profit (loss)
3,793,000,000 JPY
3,952,000,000 JPY
Non-operating income
365,000,000 JPY
253,000,000 JPY
Non-operating income
Interest income
4,000,000 JPY
1,000,000 JPY
Dividend income
204,000,000 JPY
181,000,000 JPY
Income taxes
1,242,000,000 JPY
1,210,000,000 JPY
Non-operating expenses
79,000,000 JPY
152,000,000 JPY
Profit (loss)
2,825,000,000 JPY
2,838,000,000 JPY
Non-operating expenses
Interest expenses
1,000,000 JPY
0 JPY
Extraordinary income
Gain on sale of non-current assets
2,000,000 JPY
JPY
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.